Eltek Ltd. filings document foreign private issuer reporting for a printed circuit board manufacturer whose annual reports are filed on Form 20-F and interim company updates are furnished on Form 6-K. The disclosures cover audited consolidated financial statements, quarterly and annual results, order activity, earnings-call notices and operating outlook information for its PCB business.
Eltek’s filing record also includes references to registration statements on Form F-3 and Form S-8, linking certain Form 6-K disclosures to securities registration and equity plan records. Company-specific disclosures describe HDI, multilayer and flex-rigid PCB production, defense, aerospace and medical customers, Israel-based operations, a North American subsidiary, and compliance certifications relevant to its manufacturing markets.
Eltek Ltd., a global manufacturer of high-quality printed circuit boards, filed a Form 6-K to announce the timing of its upcoming earnings release and conference call. The company will report its financial results for the first quarter of 2026 before the market opens on Tuesday, May 19, 2026.
On the same day at 8:30 a.m. Eastern Time, Eltek will host a conference call featuring Chief Executive Officer Eli Yaffe and Chief Financial Officer Ron Freund to discuss the results. The financial results and a replay of the call will be available through the Investor Info section of Eltek’s corporate website.
Eltek Ltd. reported new purchase orders totaling approximately $5.3 million from an international customer. Deliveries are scheduled to begin in the second quarter of 2026, with final shipments expected by September 2027.
The company also indicated that operating results for the first quarter of 2026 will be adversely affected by a less favorable fulfillment mix in its order backlog and unexpected logistics issues, even though its backlog has approximately doubled compared to year-end 2025. Eltek expects deliveries to gradually normalize over time.
ELTEK LTD reported that Chief Information Officer Yaniv Luria holds employee stock options over 10,000 ordinary shares with an exercise price of $9.78 expiring on August 14, 2034, and options over 15,000 ordinary shares at $8.82 expiring on March 8, 2036. Both option grants vest over four years, with 25% vesting after one year from the grant date and 6.25% at the end of each following quarter.
Eltek Ltd., a global manufacturer of advanced printed circuit boards, filed its 2025 annual report with the U.S. Securities and Exchange Commission. The filing includes audited consolidated financial statements for the year ended December 31, 2025.
The annual report is available on Eltek’s website, and shareholders can request a hard copy free of charge. Eltek highlights its focus on complex, high-quality PCB solutions for defense, aerospace, medical and other high-end markets across Israel, the United States, Europe and Asia.
Eltek Ltd., an Israel-based manufacturer of advanced custom printed circuit boards, reports on its 2025 fiscal year and outlines extensive risk factors. The company had 6,719,827 ordinary shares outstanding as of December 31, 2025 and prepares U.S. GAAP financials in U.S. dollars.
Eltek serves defense and aerospace, medical, industrial, telecom and networking customers with HDI, flex-rigid and high-layer-count rigid PCBs. Key themes include dependence on aging, unique machinery, concentration of revenues among a few large customers and suppliers, exposure to volatile raw-material markets, and sensitivity to NIS/U.S. dollar exchange rates.
The report highlights environmental compliance and penalties in Israel, potential additional remediation costs, cyber and IT risks, possible capital needs despite $12.1 million in cash and $25.0 million in working capital, as well as geopolitical and security risks arising from conflicts involving Israel, Hamas and Iran.
Eltek Ltd director Erez Meltzer has filed an initial ownership report showing holdings of employee stock options tied to Eltek ordinary shares. One option grants rights over 20,000 ordinary shares at an exercise price of $5.8900 per share, expiring on September 6, 2031. A second option covers 10,000 ordinary shares at an exercise price of $8.6700 per share, expiring on October 6, 2033. Each option vests over four years, with 25% becoming exercisable on the first anniversary of its grant date and 6.25% additional vesting at the end of each subsequent quarter.
Eltek Ltd director Cohen Tsemah Revital filed an initial ownership report showing existing employee stock options, not new share purchases or sales. The holdings include options over 3,750 ordinary shares at an exercise price of $4.94, expiring on March 24, 2031, and options over 8,000 ordinary shares at $8.70, expiring on August 3, 2033. Both option grants vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting at the end of each following quarter.
ELTEK LTD Chief Financial Officer Ron Freund filed an initial ownership report showing both ordinary shares and multiple employee stock option grants. He directly holds 7,558 ordinary shares, plus options over 58,500 ordinary shares at exercise prices ranging from $3.60 to $15.83 per share with expirations between 2031 and 2036. Footnotes state that each option grant vests over four years, with 25% vesting after one year and 6.25% vesting at the end of each subsequent quarter.
Eltek Ltd director Mordechai Marmorstein has reported existing employee stock option holdings in a Form 3 filing. He holds options over 10,000 ordinary shares at an exercise price of $5.8900 per share expiring on September 6, 2031, and options over another 10,000 ordinary shares at $8.6700 per share expiring on October 6, 2033. Each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant date and 6.25% at the end of each following quarter. The earlier grant was made on September 6, 2021, and the later grant on October 10, 2023.